Learn More
Gibco™ RPMI 1640 Medium, HEPES 
Originally developed to culture human leukemic cells in suspension and as monolayer
$25.83 - $800.00
Specifications
Requires: Supplementation
| Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
|
22400097
|
Gibco™
LS22400097 |
100mL |
Each for $25.83
|
|
22400089
|
Gibco™
LS22400089 |
500mL |
Each for $81.75
|
|
22400071
|
Gibco™
LS22400071 |
1000mL |
Each for $140.00
|
|
22400105
|
Gibco™
LS22400105 |
10 x 500mL |
Each for $736.00
|
|
22400121
|
Gibco™
LS22400121 |
6 x 1000mL |
Each for $800.00
|
|
Description
Roswell Park Memorial Institute (RPMI) 1640 Medium has since been found suitable for a variety of mammalian cells, including HeLa, Jurkat, MCF-7, PC12, PBMC, astrocytes, and carcinomas. This RPMI is modified as follows: with L-glutamine, HEPES, phenol red.
- Contains reducing agent glutathione, high concentrations of vitamin biotin, vitamin B12, and PABA
- Vitamins inositol and choline are present in high concentrations
- Contains no proteins, lipids, or growth factors
- Requires supplementation, commonly with 10% Fetal Bovine Serum (FBS)
- Uses sodium bicarbonate buffer system (2.0g/L), and therefore requires 5-10% CO2 environment to maintain physiological pH
- Sustainable packaging
Cell Culture, Mammalian Cell Culture
Order Info
Shipping Condition: Room Temperature
Specifications
| 0.0 | |
| icon-pdf.png |
Not for human or animal therapeutic use. Uses other than the intended use may be a violation of local law. Customers using Gibco RPMI 1640 in a manufacturing process, who have a submission with the FDA, may request a letter of authorization from Life Technologies to reference their Type II Drug Master File (DMF). For in vitro diagnostic use.